TGA's New Milestones: Are You Ready for the Change? Understanding Australia's Regulatory Framework Arena TGA will require DOC's to be submitted for Class I ARTG registrations PharmaLex Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia Therapeutic Innovation & Regulatory Science Springer Nature Link The growing market for injectable peptides includes many schedule 4 drugs that are not yet approved for use in Australia but can be prescribed by a doctor The Therapeutic Goods Administration has issued a safety warning, saying it's "concerned" about an increase in the importation and supply of unapproved peptides.